Auto - Parts
Compare Stocks
5 / 10Stock Comparison
MLR vs REVG vs DORM vs OSUR vs ALSN
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Auto - Parts
Medical - Instruments & Supplies
Auto - Parts
MLR vs REVG vs DORM vs OSUR vs ALSN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Parts | Agricultural - Machinery | Auto - Parts | Medical - Instruments & Supplies | Auto - Parts |
| Market Cap | $542M | $3.12B | $3.72B | $225M | $10.23B |
| Revenue (TTM) | $745M | $2.40B | $2.15B | $85M | $3.65B |
| Net Income (TTM) | $16M | $108M | $190M | $-53M | $543M |
| Gross Margin | 15.1% | 14.4% | 40.7% | 38.8% | 40.8% |
| Operating Margin | 3.0% | 7.1% | 15.6% | -58.6% | 24.1% |
| Forward P/E | 25.0x | 17.2x | 15.0x | — | 13.6x |
| Total Debt | $34M | $56M | $633M | $13M | $2.92B |
| Cash & Equiv. | $45M | $35M | $49M | $199K | $1.50B |
MLR vs REVG vs DORM vs OSUR vs ALSN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Miller Industries, … (MLR) | 100 | 160.9 | +60.9% |
| REV Group, Inc. (REVG) | 100 | 1047.5 | +947.5% |
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
| OraSure Technologie… (OSUR) | 100 | 21.5 | -78.5% |
| Allison Transmissio… (ALSN) | 100 | 326.3 | +226.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MLR vs REVG vs DORM vs OSUR vs ALSN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MLR is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.92, yield 1.7%
- Lower volatility, beta 0.92, Low D/E 8.0%, current ratio 3.22x
- Beta 0.92, yield 1.7%, current ratio 3.22x
- 1.7% yield, 2-year raise streak, vs ALSN's 0.9%, (2 stocks pay no dividend)
REVG has the current edge in this matchup, primarily because of its strength in momentum and efficiency.
- +80.3% vs DORM's +0.5%
- 8.9% ROA vs OSUR's -12.8%, ROIC 29.9% vs -20.0%
DORM is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.0%, EPS growth 8.1%, 3Y rev CAGR 7.1%
- 6.0% revenue growth vs OSUR's -38.1%
- Beta 0.85 vs REVG's 1.48
Among these 5 stocks, OSUR doesn't own a clear edge in any measured category.
ALSN ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 373.8% 10Y total return vs REVG's 174.2%
- PEG 0.60 vs DORM's 1.00
- Better valuation composite
- 14.9% margin vs OSUR's -61.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs OSUR's -38.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 14.9% margin vs OSUR's -61.9% | |
| Stability / Safety | Beta 0.85 vs REVG's 1.48 | |
| Dividends | 1.7% yield, 2-year raise streak, vs ALSN's 0.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +80.3% vs DORM's +0.5% | |
| Efficiency (ROA) | 8.9% ROA vs OSUR's -12.8%, ROIC 29.9% vs -20.0% |
MLR vs REVG vs DORM vs OSUR vs ALSN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MLR vs REVG vs DORM vs OSUR vs ALSN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REVG leads in 2 of 6 categories
ALSN leads 1 • MLR leads 0 • DORM leads 0 • OSUR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALSN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALSN is the larger business by revenue, generating $3.6B annually — 42.9x OSUR's $85M. ALSN is the more profitable business, keeping 14.9% of every revenue dollar as net income compared to OSUR's -61.9%. On growth, ALSN holds the edge at +83.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $745M | $2.4B | $2.2B | $85M | $3.6B |
| EBITDAEarnings before interest/tax | $33M | $193M | $377M | -$45M | $970M |
| Net IncomeAfter-tax profit | $16M | $108M | $190M | -$53M | $543M |
| Free Cash FlowCash after capex | $110M | $200M | $71M | -$33M | $713M |
| Gross MarginGross profit ÷ Revenue | +15.1% | +14.4% | +40.7% | +38.8% | +40.8% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +7.1% | +15.6% | -58.6% | +24.1% |
| Net MarginNet income ÷ Revenue | +2.1% | +4.5% | +8.8% | -61.9% | +14.9% |
| FCF MarginFCF ÷ Revenue | +14.8% | +8.3% | +3.3% | -38.9% | +19.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -19.8% | +11.3% | +4.2% | -99.9% | +83.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -92.8% | +68.6% | -23.5% | -52.4% | -40.4% |
Valuation Metrics
Evenly matched — MLR and OSUR and ALSN each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 16.8x trailing earnings, ALSN trades at a 50% valuation discount to REVG's 33.8x P/E. Adjusting for growth (PEG ratio), ALSN offers better value at 0.73x vs DORM's 1.25x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $542M | $3.1B | $3.7B | $225M | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $531M | $3.1B | $4.3B | $238M | $11.7B |
| Trailing P/EPrice ÷ TTM EPS | 24.07x | 33.81x | 18.75x | -3.33x | 16.79x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.95x | 17.18x | 15.05x | — | 13.60x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.25x | — | 0.73x |
| EV / EBITDAEnterprise value multiple | 11.52x | 14.35x | 10.41x | — | 10.63x |
| Price / SalesMarket cap ÷ Revenue | 0.69x | 1.27x | 1.75x | 1.96x | 3.40x |
| Price / BookPrice ÷ Book value/share | 1.32x | 7.73x | 2.59x | 0.67x | 5.60x |
| Price / FCFMarket cap ÷ FCF | 6.38x | 16.41x | 49.18x | — | 15.77x |
Profitability & Efficiency
REVG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ALSN delivers a 29.5% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $-15 for OSUR. OSUR carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALSN's 1.56x. On the Piotroski fundamental quality scale (0–9), REVG scores 7/9 vs OSUR's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.7% | +27.9% | +13.1% | -15.1% | +29.5% |
| ROA (TTM)Return on assets | +2.6% | +8.9% | +7.6% | -12.8% | +8.4% |
| ROICReturn on invested capital | +5.5% | +29.9% | +13.9% | -20.0% | +22.2% |
| ROCEReturn on capital employed | +6.8% | +27.0% | +18.5% | -16.8% | +18.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 7 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.08x | 0.13x | 0.43x | 0.04x | 1.56x |
| Net DebtTotal debt minus cash | -$11M | $21M | $584M | $13M | $1.4B |
| Cash & Equiv.Liquid assets | $45M | $35M | $49M | $199,278 | $1.5B |
| Total DebtShort + long-term debt | $34M | $56M | $633M | $13M | $2.9B |
| Interest CoverageEBIT ÷ Interest expense | 31.35x | 6.03x | 8.24x | — | 64.20x |
Total Returns (Dividends Reinvested)
REVG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REVG five years ago would be worth $36,117 today (with dividends reinvested), compared to $3,174 for OSUR. Over the past 12 months, REVG leads with a +80.3% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors REVG at 85.2% vs OSUR's -23.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.9% | +2.6% | +0.3% | +31.5% | +24.7% |
| 1-Year ReturnPast 12 months | +14.7% | +80.3% | +0.5% | +12.2% | +27.7% |
| 3-Year ReturnCumulative with dividends | +49.6% | +535.6% | +41.6% | -55.2% | +162.2% |
| 5-Year ReturnCumulative with dividends | +18.0% | +261.2% | +19.2% | -68.3% | +183.5% |
| 10-Year ReturnCumulative with dividends | +168.1% | +174.2% | +129.7% | -53.1% | +373.8% |
| CAGR (3Y)Annualised 3-year return | +14.4% | +85.2% | +12.3% | -23.5% | +37.9% |
Risk & Volatility
Evenly matched — MLR and DORM each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than REVG's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MLR currently trades 95.5% from its 52-week high vs DORM's 74.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 1.48x | 0.85x | 1.45x | 1.11x |
| 52-Week HighHighest price in past year | $49.88 | $69.92 | $166.89 | $3.82 | $137.42 |
| 52-Week LowLowest price in past year | $33.81 | $34.96 | $98.44 | $2.08 | $76.01 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +91.4% | +74.6% | +81.9% | +89.6% |
| RSI (14)Momentum oscillator 0–100 | 58.9 | 50.6 | 71.2 | 47.1 | 50.9 |
| Avg Volume (50D)Average daily shares traded | 89K | 1.6M | 273K | 473K | 814K |
Analyst Outlook
Evenly matched — MLR and ALSN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MLR as "Hold", REVG as "Hold", DORM as "Buy", OSUR as "Hold", ALSN as "Hold". Consensus price targets imply 27.8% upside for OSUR (target: $4) vs -13.9% for REVG (target: $55). For income investors, MLR offers the higher dividend yield at 1.65% vs REVG's 0.40%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $48.50 | $55.00 | $140.00 | $4.00 | $116.00 |
| # AnalystsCovering analysts | 3 | 12 | 16 | 13 | 29 |
| Dividend YieldAnnual dividend ÷ price | +1.7% | +0.4% | — | — | +0.9% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 2 | 2 | 6 |
| Dividend / ShareAnnual DPS | $0.79 | $0.26 | — | — | $1.07 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +3.5% | +1.1% | +6.7% | +3.2% |
REVG leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ALSN leads in 1 (Income & Cash Flow). 3 tied.
MLR vs REVG vs DORM vs OSUR vs ALSN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MLR or REVG or DORM or OSUR or ALSN a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus -38. 1% for OraSure Technologies, Inc. (OSUR). Allison Transmission Holdings, Inc. (ALSN) offers the better valuation at 16. 8x trailing P/E (13. 6x forward), making it the more compelling value choice. Analysts rate Dorman Products, Inc. (DORM) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MLR or REVG or DORM or OSUR or ALSN?
On trailing P/E, Allison Transmission Holdings, Inc.
(ALSN) is the cheapest at 16. 8x versus REV Group, Inc. at 33. 8x. On forward P/E, Allison Transmission Holdings, Inc. is actually cheaper at 13. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Allison Transmission Holdings, Inc. wins at 0. 60x versus Dorman Products, Inc. 's 1. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MLR or REVG or DORM or OSUR or ALSN?
Over the past 5 years, REV Group, Inc.
(REVG) delivered a total return of +261. 2%, compared to -68. 3% for OraSure Technologies, Inc. (OSUR). Over 10 years, the gap is even starker: ALSN returned +373. 8% versus OSUR's -53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MLR or REVG or DORM or OSUR or ALSN?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus REV Group, Inc. 's 1. 48β — meaning REVG is approximately 73% more volatile than DORM relative to the S&P 500. On balance sheet safety, OraSure Technologies, Inc. (OSUR) carries a lower debt/equity ratio of 4% versus 156% for Allison Transmission Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MLR or REVG or DORM or OSUR or ALSN?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus -38. 1% for OraSure Technologies, Inc. (OSUR). On earnings-per-share growth, the picture is similar: Dorman Products, Inc. grew EPS 8. 1% year-over-year, compared to -261. 5% for OraSure Technologies, Inc.. Over a 3-year CAGR, DORM leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MLR or REVG or DORM or OSUR or ALSN?
Allison Transmission Holdings, Inc.
(ALSN) is the more profitable company, earning 20. 7% net margin versus -59. 8% for OraSure Technologies, Inc. — meaning it keeps 20. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALSN leads at 32. 3% versus -59. 2% for OSUR. At the gross margin level — before operating expenses — ALSN leads at 48. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MLR or REVG or DORM or OSUR or ALSN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Allison Transmission Holdings, Inc. (ALSN) is the more undervalued stock at a PEG of 0. 60x versus Dorman Products, Inc. 's 1. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Allison Transmission Holdings, Inc. (ALSN) trades at 13. 6x forward P/E versus 25. 0x for Miller Industries, Inc. — 11. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OSUR: 27. 8% to $4. 00.
08Which pays a better dividend — MLR or REVG or DORM or OSUR or ALSN?
In this comparison, MLR (1.
7% yield), ALSN (0. 9% yield), REVG (0. 4% yield) pay a dividend. DORM, OSUR do not pay a meaningful dividend and should not be held primarily for income.
09Is MLR or REVG or DORM or OSUR or ALSN better for a retirement portfolio?
For long-horizon retirement investors, Miller Industries, Inc.
(MLR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 1. 7% yield, +168. 1% 10Y return). Both have compounded well over 10 years (MLR: +168. 1%, OSUR: -53. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MLR and REVG and DORM and OSUR and ALSN?
These companies operate in different sectors (MLR (Consumer Cyclical) and REVG (Industrials) and DORM (Consumer Cyclical) and OSUR (Healthcare) and ALSN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MLR is a small-cap quality compounder stock; REVG is a small-cap quality compounder stock; DORM is a small-cap quality compounder stock; OSUR is a small-cap quality compounder stock; ALSN is a mid-cap deep-value stock. MLR, ALSN pay a dividend while REVG, DORM, OSUR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.